Hepatic molecular characteristics of patients with varying degrees of nonalcoholic steatohepatitis compared to healthy normal weight individuals
American Journal of Physiology - Gastroenterology and Liver Physiology 316(4):G462-G472, 2019
Animal models of type 2 diabetes, obesity and nonalcoholic steatohepatitis – clinical translatability and applicability in preclinical drug development
In: Krentz A., Weyer C., Hompesch M. (eds) Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. Springer, Cham. pp 369-403, 2019
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach
Molecular Metabolism 21:36-50, 2019
Bariatric surgery in patients with non-alcoholic fatty liver disease – from pathophysiology to clinical effects
World Journal of Hepatology 11(2):138-149, 2019
Adrenomedullin and glucagon-like peptide-1 have additive effects on food intake in mice
Biomedicine & Pharmacotherapy 109:167-173, 2019
Disease progression and pharmacological intervention in a nutrient-deficient rat model of nonalcoholic steatohepatitis
Digestive Diseases and Sciences 64(5):1238-1256, 2019
Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice
Physiology and Behavior 192:72-81, 2018